Manning & Napier Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Buy
77,663
+28,590
+58% +$761K 0.03% 227
2025
Q4
$1.23M Buy
+49,073
New +$1.24M 0.02% 231
2017
Q3
$29.9M Buy
883,259
+2,085
+0.2% +$67K 0.26% 70
2017
Q2
$28.1M Buy
881,174
+122,892
+16% +$3.88M 0.24% 73
2017
Q1
$24.6M Buy
758,282
+37,346
+5% +$1.18M 0.19% 71
2016
Q4
$22.2M Buy
720,936
+41,079
+6% +$1.25M 0.15% 75
2016
Q3
$21.8M Sell
679,857
-6,339
-0.9% -$212K 0.13% 69
2016
Q2
$22.9M Sell
686,196
-79,282
-10% -$2.53M 0.14% 69
2016
Q1
$21.5M Sell
765,478
-9,245
-1% -$264K 0.12% 74
2015
Q4
$23.7M Sell
774,723
-23,896
-3% -$752K 0.14% 75
2015
Q3
$23.8M Sell
798,619
-37,964
-5% -$1.22M 0.13% 85
2015
Q2
$26.6M Sell
836,583
-87,057
-9% -$2.84M 0.12% 91
2015
Q1
$30.5M Sell
923,640
-7,642
-0.8% -$243K 0.14% 94
2014
Q4
$27.5M Buy
931,282
+43,323
+5% +$1.24M 0.12% 99
2014
Q3
$24.9M Sell
887,959
-42,003
-5% -$1.18M 0.1% 107
2014
Q2
$26.2M Sell
929,962
-17,775
-2% -$507K 0.1% 107
2014
Q1
$28.9M Sell
947,737
-135,073
-12% -$4.03M 0.12% 101
2013
Q4
$31.5M Sell
1,082,810
-96,627
-8% -$2.81M 0.14% 91
2013
Q3
$32.1M Buy
1,179,437
+1,764
+0.1% +$48K 0.15% 85
2013
Q2
$31.3M Buy
+1,177,673
New +$32.5M 0.17% 82

Other funds holding PFE

Manning & Napier Advisors's PFE Position: Q1 2026 in Review

Manning & Napier Advisors increased its Pfizer (PFE) stake by 58% in Q1 2026, buying an estimated $761K and bringing the position to 77,663 shares worth $2.18M. The position accounts for 0.03% of the portfolio, ranked #227.

Manning & Napier Advisors first reported a position in PFE in Q2 2013 and has held it in 20 quarters since. The position peaked at $32.1M in Q3 2013. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Manning & Napier Advisors held 77,663 shares of Pfizer worth $2.18M as of Q1 2026.
  • Manning & Napier Advisors bought 28,590 Pfizer shares in Q1 2026, an estimated $761K.
  • Pfizer made up 0.03% of Manning & Napier Advisors's portfolio in Q1 2026, its #227 holding.
  • Manning & Napier Advisors first reported a position in Pfizer in Q2 2013 and has held it in 20 quarters since.
  • Manning & Napier Advisors's Pfizer position peaked at $32.1M in Q3 2013.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.